TCOYD Home
Click a city below for information:

Providence, RI
Conference & Health Fair
September 11th

San Diego, CA
Latino Mini Series
Septiembre 13th

San Diego, CA
Mini Series Event
September 22nd

Des Moines, IA
Conference & Health Fair
September 25th

San Diego, CA
Conference & Health Fair
October 30th

A Day at TCOYD
View More TV

TCOYD TV: The Discovery of Incretin Hormones - A Powerful Tool to Fight Type 2 Diabetes and Obesity

Original Air Date - 2.9.2009

In this important episode, Dr. Steven Edelman and Dr. Robert Henry review the discovery and crucial role of incretin hormones, namely exenatide, in glucose control. A missing piece in weight and blood sugar control for those with type 2 diabetes is revealed.

Recommend this Video

Related Articles:

Victoza (liraglutide) for Type 2 Diabetes: the Once Daily GLP-1 Incretin Mimetic

In January of 2010, the Food and Drug Administration (FDA) approved the use of Victoza (liraglutide) in the United States in adults with type 2 diabetes in order to improve glycemic control in addition to diet and exercise. Now, Victoza joins Byetta (exenatide) in the class of drugs called GLP-1s.

Read more...
Incretin Mimetics

Steven V. Edelman, MD
TCOYD Newsletter, Vol. 25, 2008

Developments in an Important Class of Treatments for Type 2 Diabetes

Diabetes affects multiple hormones in the body; not just insulin. Incretins are hormones released from the intestines after eating that cause insulin secretion and appetite suppression.

Read more...
 
[ Back ]

Platinum Sponsors